CD81 and breast cancer: CD105 (p = 0.001) and CD40 (p = 0.006) were further confirmed as factors that clearly distinguished EVs derived from BC cells co-cultured with ECs, along with CD81 as correlated to co-cultured phenotype (p = 0.0005).